InvestWiser

Bavarian Nordic

BAVANasdaq CopenhagenHealthcareMarket value 18.5 bn DKK
248.20DKK +0.8%
last day · Price as of 19 November 2026

The answer first

Does Bavarian Nordic beat the market?

Yes, Bavarian Nordic has beaten the market over the last year.

Bavarian Nordic+35.8%København (OMXCGI)+13.9%
  • The ranking · Quality, value and trend combined

    Better than 93% of Nordic stocks

    • Quality78
    • Value55
    • Trend92

    No. 6 of 195 in healthcare

  • Expectations in the price

    Moderate expectations

    For the share to return about 9% a year from today's price, the cash Bavarian Nordic keeps must grow about 7% a year for 10 years.

Max for seven days

Follow Bavarian Nordic with Aurora

Aurora lets you know at the next report. No card.

Both with dividends. Figures as of 19 November 2026. General analysis, not personal advice.

Follow your thesis

Follow your thesis on Bavarian Nordic

From today, at a price of 248.20 DKK. Write why you follow Bavarian Nordic, and choose what Aurora should tell you about.

What should Aurora follow?

Free, no card. The mission is ready when your account is.

Aurora tells you that something happened. What you do is your choice.

Ask Aurora about Bavarian Nordic

Your first answer is free, no account needed.

Do you own Bavarian Nordic, or are you thinking about it?

See it next to the rest of your portfolio, or build your first one with Bavarian Nordic and a few more. Free, no card.

Past year against the exchange and Super Stock
Bavarian Nordic+35.8%København (OMXCGI)+13.9%Super Stock+44.6%
17 November 202519 November 2026
All start at 0 % a year ago, with dividends. Super Stock is our model portfolio: the 20 highest-ranked Nordic stocks on quality, value and trend.

In short

  • Bavarian Nordic has risen 35.8% over the past year, including dividends.
  • Overall, Bavarian Nordic ranks better than 93% of Nordic stocks on quality, value and trend.
  • The largest fall over the past three years was 66.0%. The price is 39.5% below its peak now.

What do analysts think of Bavarian Nordic?

Quality, value and trend

Quality is about the company, value about the price you pay, and trend about the share price. Each pillar shows the numbers it is built on.

93

Quality, value and trend together. Better than 93% of Nordic stocks.

No. 6 of 195 in healthcare

Quality78
The company · Fundamentals: the accounts

High A solid company: it earns well on its money and has healthy finances.

No. 59 of 196 in healthcareTypical in healthcare: 64Typical in the Nordics: 50

  • Debt to equityBorrowings divided by equity0.01
  • Asset turnoverSales divided by everything the company owns0.42
  • Return on equityProfit divided by equity+6.6%
  • Cash conversionOperating cash flow divided by profit1.15

The ranking is built on equity ratio, ROA and how steadily profit grows.

Value55
The price · Valuation: the multiples

Medium Fair price: about the same as a typical Nordic stock.

No. 42 of 197 in healthcareTypical in healthcare: 20Typical in the Nordics: 50

  • P/BPrice divided by equity1.3
  • P/SPrice divided by sales2.9
  • P/EPrice divided by earnings20.2
  • P/CFPrice divided by operating cash flow17.1

The ranking is built on P/E, P/B and P/S.

Trend92
The share price · Technical: the price trend

High Tailwind in the share price: it has risen more than most over the last year.

No. 20 of 198 in healthcareTypical in healthcare: 34Typical in the Nordics: 50

  • 3 months+16.0%
  • 6 months+23.4%
  • 9 months+26.7%
  • 12 months+35.8%

The ranking is built on 3, 6 and 12–1 months.

Return and risk

1 month
+1.8%
3 years, per year
+19.9%
5 years, per year
−4.0%
10 years, per year
+2.6%
Largest fall, 3 years
−66.0%
From a peak to the bottom
From the peak now
−39.5%
How far the price is from the peak
Volatility, 1 year
26.6%
How much the price swings over a year
Beta, 1 year
0.50
How much the price moves when the market moves

Return with dividends reinvested.

The funds that own Bavarian Nordic

14 funds we follow own Bavarian Nordic. The share is how much of the fund the stock makes up.

  • Norway3
  • Sweden5
  • Denmark6
  • 1 ETF

From the funds' latest known holdings.

About Bavarian Nordic

Bavarian Nordic is a company in healthcare, listed on Nasdaq Copenhagen. The share trades in DKK. It has around 1,700 employees.

Bavarian Nordic A/S develops, manufactures, and supplies life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; Vaxchora, an oral vaccine for immunization against cholera; and Vivotif/Typhoral, an oral vaccine for immunization against typhoid fever. It is also developing MVA-BN WEV, that is in phase 2 trial for the treatment of encephalitis viruses.

See the full analysis of Bavarian Nordic.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

Free forever · No card

Other healthcare stocks on Nasdaq Copenhagen

Explore the stock market